Published in J Med Genet on November 01, 1997
Identification and characterization of a spinal muscular atrophy-determining gene. Cell (1995) 17.41
The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell (1995) 5.50
The limb-girdle muscular dystrophies--proposal for a new nomenclature. Neuromuscul Disord (1995) 1.95
Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol (1994) 3.44
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery (1990) 2.91
Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88
Structure of a major immunogenic site on foot-and-mouth disease virus. Nature (1993) 2.55
Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet (1999) 2.49
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J (1999) 2.28
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93
Predictive testing for Huntington's disease with linked DNA markers. Lancet (1989) 1.90
Rapid detection of single base mismatches as heteroduplexes on Hydrolink gels. Trends Genet (1991) 1.83
A high molecular weight precursor of luteinizing hormone releasing hormone from rat hypothalamus. Endocrinology (1983) 1.81
Prenatal exclusion testing for Huntington's disease: a problem of too much information. J Med Genet (1989) 1.70
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet (1999) 1.67
Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy. J Med Genet (2004) 1.63
Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain. Nature (1988) 1.63
Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry (2010) 1.60
Risk assessment of antibiotic residues of beta-lactams and macrolides in food products with regard to their immuno-allergic potential. Food Chem Toxicol (1991) 1.56
Guidance and activation of murine macrophages by nanometric scale topography. Exp Cell Res (1996) 1.56
Characterization of a phosphatidylinositol-specific phosphoinositide 3-kinase from mammalian cells. Curr Biol (1994) 1.55
Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis. J Med Genet (2000) 1.50
Aortic aneurysm morphology for planning endovascular aortic grafts: limitations of conventional imaging methods. J Endovasc Surg (1995) 1.48
Influence of the teacher-student relationship on childhood conduct problems: a prospective study. J Clin Child Psychol (1999) 1.47
Use of linkage disequilibrium data in prenatal diagnosis of cystic fibrosis. Hum Genet (1988) 1.47
Interstitial cells of cajal and inflammation-induced motor dysfunction in the mouse small intestine. Gastroenterology (2000) 1.44
Paralysis of horses associated with equine herpesvirus 1 infection. J Am Vet Med Assoc (1971) 1.43
Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J (1993) 1.42
Genetic differences between cystic fibrosis with and without meconium ileus. Lancet (1989) 1.40
Paying for hospital emergency care under a single-payer system. Ann Emerg Med (2001) 1.40
Options for prenatal testing for Huntington's disease using linked DNA probes. J Med Genet (1990) 1.39
A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2p. Hum Mol Genet (1994) 1.38
Casemix classification for outpatient services based on episodes of care. Med J Aust (1993) 1.38
Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology (2000) 1.36
Reading grade levels and health behaviors of parents at child clinics. Kans Med (1995) 1.34
Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31
Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations. Leukemia (2005) 1.31
Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol (1997) 1.29
Atmosphere-surface interactions on Mars: delta 17O measurements of carbonate from ALH 84001. Science (1998) 1.27
Neuroferritinopathy in a French family with late onset dominant dystonia. J Med Genet (2003) 1.24
Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure (1996) 1.24
Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord (2000) 1.22
Synergistic and hierarchical adhesive and topographic guidance of BHK cells. Exp Cell Res (1996) 1.20
Genetic heterogeneity in hereditary haemorrhagic telangiectasia. J Med Genet (1994) 1.20
A submicroscopic translocation, t(4;10), responsible for recurrent Wolf-Hirschhorn syndrome identified by allele loss and fluorescent in situ hybridisation. J Med Genet (1992) 1.18
Activation of macrophage-like cells by multiple grooved substrata. Topographical control of cell behaviour. Cell Biol Int (1995) 1.18
Volumetric magnetic resonance imaging evidence of bilateral hippocampal atrophy in mesial temporal lobe epilepsy. Epilepsia (1997) 1.17
The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transbound Emerg Dis (2011) 1.15
Impaired recognition of disgust in Huntington's disease gene carriers. Brain (1997) 1.13
Towards a duty of care for biodiversity. Environ Manage (2010) 1.10
Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy. Curr Opin Neurol (1996) 1.10
Prenatal exclusion testing for Huntington disease using the polymerase chain reaction. Am J Med Genet (1989) 1.09
Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. Structure (1995) 1.09
Outbreak of Japanese encephalitis on the island of Saipan, 1990. J Infect Dis (1993) 1.08
The haplotype distribution of the delta F508 mutation in cystic fibrosis families in Scotland. Hum Genet (1990) 1.07
Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus. J Virol (2001) 1.07
Quality of life as conveyed by pediatric patients with cancer. Qual Life Res (2004) 1.07
Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport (1998) 1.02
Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord (2001) 1.02
A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J Biol Chem (2000) 1.01
A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21. Am J Hum Genet (1993) 1.00
Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy. Neuromuscul Disord (1996) 1.00
The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach. Neuromuscul Disord (2001) 1.00
Synthesis of phosphatidylinositol 3,4,5-trisphosphate in permeabilized neutrophils regulated by receptors and G-proteins. J Biol Chem (1993) 0.99
Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis. J Med Genet (1996) 0.98
A genetic animal model of human neocortical heterotopia associated with seizures. J Neurosci (1997) 0.98
Simple measures to reduce the rate of contamination of blood cultures in Accident and Emergency. Emerg Med J (2005) 0.98
Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame. J Med Genet (1992) 0.96
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet (1993) 0.96
Multiphase mechanics of capsule formation in tumors. J Biomech Eng (2002) 0.96
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest (1995) 0.96
Protein kinase Cs. Coping with a growing family. Nature (1987) 0.95
Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Genes Chromosomes Cancer (1997) 0.95
Hernia of the lung: a case report and review of literature. Conn Med (1997) 0.94
Axial computed tomography of the pedicle in the lower cervical spine. Am J Orthop (Belle Mead NJ) (2001) 0.94
Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol (1997) 0.94
Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy. Arch Dis Child (1993) 0.94
The ras gene. Transformer and transducer. Nature (1987) 0.93
Becker muscular dystrophy with onset after 60 years. Neurology (1994) 0.92
Extensive metazoan reefs from the Ediacaran Nama Group, Namibia: the rise of benthic suspension feeding. Geobiology (2014) 0.92
Enalapril overdose treated with angiotensin infusion. Lancet (1993) 0.92
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients. J Med Genet (1993) 0.91
First-trimester prenatal diagnosis of cystic fibrosis by direct gene probing. Lancet (1989) 0.91
Primary leiomyosarcoma of gallbladder seen on computed tomography and ultrasound. Am J Gastroenterol (1986) 0.90
Evaluation of Gonodecten for the presumptive diagnosis of gonococcal urethritis in men. J Clin Microbiol (1985) 0.90
Part I: propofol, thiopental, sevoflurane, and isoflurane-A randomized, controlled trial of effectiveness. Anesth Analg (2000) 0.90
Percutaneous absorption and skin irritation of JP-8 (jet fuel). Toxicology (2001) 0.89
Attitudes towards prenatal HIV testing and treatment among pregnant women in southern India. Int J STD AIDS (2001) 0.89
Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach. Eur J Hum Genet (2000) 0.89
Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis (1988) 0.89
Linkage disequilibrium and recombination make a telomeric site for the Huntington's disease gene unlikely. J Med Genet (1991) 0.89
Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis. J Rheumatol (1989) 0.89
Population screening in cystic fibrosis. J R Soc Med (1993) 0.88
Modified sutureless sclerotomies in pars plana vitrectomy. Am J Ophthalmol (2000) 0.88
cDNA sequence of human beta-preprotachykinin, the common precursor to substance P and neurokinin A. FEBS Lett (1986) 0.88
Population dynamics and competition in chemostat models with adaptive nutrient uptake. J Math Biol (1997) 0.87